Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
iAnthus Capital Holdings, Inc. manages and operates a network of licensed cannabis cultivation, processing, and retail dispensary facilities across the United States. The company's diverse product portfolio includes raw cannabis biomass such as pre-rolls, various cannabis-infused items like topical creams and edibles, and a selection of concentrated products such as vape cartridges, live resins, waxes, oils, and tinctures. They also produce and distribute a range of cannabidiol (CBD) products, including topical creams, tinctures, and sprays, alongside a dedicated line of CBD-infused beauty and skincare essentials like lotions, creams, haircare items, lip balms, and bath bombs. iAnthus participates in both the wholesale distribution and direct-to-consumer retail of its CBD offerings. Its operational footprint spans 8 states, encompassing ownership or management of 32 dispensaries and 10 cultivation or processing sites. Founded in 2014, the company is headquartered in New York, New York.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA.